Alpha Teknova, Inc. (TKNO )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol TKNO
- Company Alpha Teknova, Inc.
- Price $7.74
- Changes Percentage 24.64
- Change 1.53
- Day Low $6.5
- Day High $8.36
- Year High $8.36
- Year Low $1.16
- Market Cap $412,601,598
- Price Avg 50 EMA (D) $5.75
- Price Avg 200 EMA (D) $3.43
- Exchange NASDAQ
- Volume 756,228
- Average Volume 211,368
- Open $6.51
- Previous Close $6.21
- EPS -0.79
- PE -9.80
- Earnings Announcement 2025-03-10 04:00:00
- Shares Outstanding $53,307,700
Company brief: ALPHA TEKNOVA, INC. (TKNO )
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Mr. Stephen Gunstream
- https://www.teknova.com
- US
- N/A
- 06-25-2021
- US02080L1026
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.